Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
13
PTHS Quote, Financials, Valuation and Earnings
Last price:
$26.92
Seasonality move
:
225.3%
Day range:
$24.21 - $27.07
52-week range:
$5.62 - $54.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.07x
P/B ratio:
0.30x
Volume:
34.3K
Avg. volume:
28.8K
1-year change:
301.97%
Market cap:
$17.5M
Revenue:
--
EPS (TTM):
-$14.19
Earnings Data
Next earnings date for PTHS
Mar 26
2026
Most recent earnings per share
-$5.30
Missed by $4.73
(Nov 13/2025)
Consensus Estimate
-$0.58
(Nov 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PTHS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/26/2026 | Q4 | $13.9M | -- | -- | -$2.68 | -- |
| 11/13/2025 | Q3 | $4.4M | $7.4M | -$5.30 | -$0.58 | -$4.73 |
| 06/30/2025 | Q2 | -- | -- | -$5.38 | -$6.26 | $0.88 |
| 03/31/2025 | Q1 | -- | -- | -$3.21 | -- | -- |
| 12/31/2024 | Q4 | -- | -- | -$3.20 | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$0.29 | -$2.30 | $2.01 |
| 06/30/2024 | Q2 | -- | -- | -$0.31 | -$2.90 | $2.59 |
| 03/31/2024 | Q1 | -- | -- | -$0.44 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.69 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.25 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.17 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.17 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.13 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.10 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.06 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.05 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.23 | -- | -- |
Pelthos Therapeutics, Inc. Earnings Questions
-
How Much did Pelthos Therapeutics, Inc. Generate in Revenue Last Quarter?
Pelthos Therapeutics, Inc. reported $7.4M worth of top line sales in its most recent quarter.
-
Did Pelthos Therapeutics, Inc. Beat Earnings Last Quarter?
Pelthos Therapeutics, Inc. announced earnings per share of -$5.30 which represents a miss of analyst forecast a -$0.58 per share.
-
Is Pelthos Therapeutics, Inc. Profitable?
Pelthos Therapeutics, Inc. reported $4M that represents $1.31 per share over the last quarter.
-
What is the Analyst Consensus for Pelthos Therapeutics, Inc. EPS Next Year?
Pelthos Therapeutics, Inc.'s earnings are forecast to decrease from -$14.27 per share to -$15.18 per share next year representing a decrease of -1.71%.
-
When is Pelthos Therapeutics, Inc.'s Earnings Date?
Pelthos Therapeutics, Inc.'s next earnings date is March 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
50
TGL alert for Dec 8
Treasure Global, Inc. [TGL] is up 30.31% over the past day.
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 41.83% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 8.06% over the past day.
